Demant A/S FCF Yield
The Free Cash Flow Yield of Demant A/S (DEMANT.CO) as of Oct 8, 2026 is 8.70 %. In the previous year, Free Cash Flow Yield was 8.69 % — a change of 0.03% (higher).
Get this data via API
Financial Data API
FCF Yield
8.70 %
YoY
0.03%
Last updated:
Free Cash Flow Yield of Demant A/S is 2025 8.70 % . Free Cash Flow Yield of Demant A/S was 2024 8.69 % . It decreases by 0.03% higher compared to the previous year.
The Demant A/S FCF Yield history
3 Years
10 Years
25 Years
Max
FCF Yield
Date
FCF Yield
Jan 1, 2018
2.81 DKK
Jan 1, 2019
3.64 DKK
Jan 1, 2020
5.11 DKK
Jan 1, 2021
6.72 DKK
Jan 1, 2022
4.47 DKK
Jan 1, 2023
9.70 DKK
Jan 1, 2024
8.69 DKK
Jan 1, 2025
8.70 DKK
| YEAR | FCF Yield | YoY |
|---|---|---|
| 8.70 % | +0.03% | |
| 8.69 % | -10.32% | |
| 9.70 % | +116.78% | |
| 4.47 % | -33.49% | |
| 6.72 % | +31.60% | |
| 5.11 % | +40.27% | |
| 3.64 % | +29.86% | |
| 2.81 % | -25.73% | |
| 3.78 % | +18.71% | |
| 3.18 % | +4.95% | |
| 3.03 % | +10.35% | |
| 2.75 % | — |
Access this data via the Eulerpool API
Demant A/S Stock analysis
What does Demant A/S do? Demant A/S is a Danish company that operates in the field of hearing technology. It was founded in 1904 and is headquartered in Smørum, Denmark. The company has several subsidiaries in various countries, including the USA, Germany, France, and China.
The history of Demant began with the founding of the company Oticon by Hans Demant in Copenhagen in 1904. Oticon was the first company to manufacture and sell hearing aids. Since then, the company has evolved into a leading provider of hearing aids, cochlear implants, and assistive listening devices.
Demant's business model is based on the development and marketing of hearing technology products. The company is divided into several business areas, including hearing aids, cochlear implants, and diagnostics and consumables.
In the field of hearing aids, Demant offers a wide range of products tailored to the needs of different customer groups. These range from basic hearing aids to high-end products with artificial intelligence.
Demant's cochlear implant system is a groundbreaking technology that enables deaf or hard-of-hearing individuals to hear. It consists of an implanted device and an external speech processor.
Demant's diagnostics and consumables business includes a variety of products used by medical professionals for the diagnosis and treatment of hearing disorders. These include earplugs, audiometry devices, tympanometry devices, and others.
Demant is also active in many other areas, including research, development, and production of hearing technology products. The company has a strong global network of partners, distributors, and customers that further strengthens its position as a leading provider of hearing technology products.
Overall, Demant has developed a deep understanding of the needs and requirements of people with hearing problems through its commitment to excellence and innovation. With its wide range of products, global network, and deep commitment to customer satisfaction, Demant has become a trusted name in hearing technology. Demant A/S is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Demant A/S stock
Free Cash Flow Yield of Demant A/S is 8.70 % in 2025.
Free Cash Flow Yield of Demant A/S changed from 8.69 % to 8.70 %, representing a 0.03% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Free Cash Flow Yield Demant A/S since 2006 – with annual values, charts, and detailed analysis.
FCF Yield measures the free cash flow per share relative to the stock price. It indicates how much cash a company generates for each dollar invested.
To evaluate Free Cash Flow Yield's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Yield.
A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Yield's Demant A/S with sector peers and the industry average to assess whether it is attractive.
Access this data via the Eulerpool API
Valuation — Demant A/S
All Key Metrics — Demant A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth